- $10.57bn
- $12.86bn
- $2.76bn
- 89
- 35
- 56
- 64
Annual income statement for Revvity, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2021 January 3rd | R2022 January 2nd | 2023 December 31st | 2023 January 1st | 2024 December 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,783 | 3,828 | 2,751 | 3,312 | 2,755 |
| Cost of Revenue | |||||
| Gross Profit | 2,110 | 2,434 | 1,540 | 1,990 | 1,538 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,804 | 2,569 | 2,450 | 2,569 | 2,408 |
| Operating Profit | 979 | 1,258 | 301 | 743 | 347 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 906 | 1,204 | 183 | 652 | 316 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 728 | 889 | 180 | 513 | 283 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 728 | 943 | 693 | 569 | 270 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 728 | 943 | 693 | 569 | 270 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 6.75 | 8.14 | 2.23 | 4.31 | 2.85 |
| Dividends per Share |